发明名称 Needleless delivery systems
摘要 A method of treating a prostate condition, including the steps of providing a needleless injector that includes a body at a proximal end, an injection shaft extending from the body to a distal end of the injection shaft, an injection orifice at the distal end of the injection shaft and positioned for fluid ejection in a lateral direction relative to a longitudinal axis of the injection shaft, a pressure source in communication with the fluid chamber, and an extendable tissue tensioner located at the distal end of the injection shaft proximal to the injection orifice; inserting the injection shaft into a urethra so the injection orifice is located within the prostatic urethra; actuating the tissue tensioner to contact urethral tissue, and injecting fluid from the injection orifice into the prostate.
申请公布号 US8986244(B2) 申请公布日期 2015.03.24
申请号 US201213569782 申请日期 2012.08.08
申请人 AMS Research Corporation 发明人 Copa Vincent G.;Hauschild Sidney F.
分类号 A61M5/30;A61M37/00;A61M25/00;A61M25/10;A61M31/00 主分类号 A61M5/30
代理机构 Kagan Binder, PLLC 代理人 Kagan Binder, PLLC
主权项 1. A method of treating a prostate condition, the method comprising the steps of: preparing a needleless injector for insertion into a patient, the injector comprising: a body at a proximal end;a first shaft extending distally from the body and having a distal end;an injection shaft extending from the body and comprising a distal end, the injection shaft being moveable along a length of the first shaft, wherein the distal end of the injection shaft is proximal to the distal end of the first shaft;an injection orifice at the distal end of the injection shaft in fluid communication with a fluid chamber at the proximal end of the body, the injection orifice being positioned for fluid ejection in a lateral direction relative to a longitudinal axis of the injection shaft and located within the first shaft, wherein the injection orifice is axially moveable along the longitudinal axis; a pressure source in communication with the fluid chamber;and an extendable tissue tensioner located at the distal end of the injection shaft proximal to the injection orifice; inserting the injection shaft into a urethra so the injection orifice is located within the prostatic urethra, actuating the tissue tensioner to contact urethral tissue, and injecting fluid from the injection orifice directly onto a prostate tissue surface.
地址 Minnetonka MN US
您可能感兴趣的专利